Chewy Announces FY2025 Results, Awaiting Critical Margin Guidance and FY2026 Outlook

What happened

Chewy has released its fiscal fourth quarter and full year 2025 financial results as scheduled on March 25, 2026, a key catalyst highlighted in prior analysis for its implications on the operating leverage thesis. This announcement triggers a pivotal moment for investors, who must now scrutinize the forthcoming detailed data and management commentary for FY2026 guidance. The DeepValue report emphasized that Chewy's investment thesis hinges on sustained gross margin expansion from structural drivers like sponsored ads and Autoship penetration, with Q3 FY2025 gross margin at 29.8% serving as a benchmark. Without specific numbers in the press release, the market faces uncertainty, requiring vigilance against potential propaganda in the full disclosure. This event tests the narrative that supports a potential buy rating, with success dependent on clear signs of margin-led profitability gains in a competitive, low-growth pet category.

Implication

The release of FY2025 results marks a decisive checkpoint for Chewy's investment case, where failure to show continued gross margin growth above 29.8% could break the operating leverage story and pressure the stock further. Success hinges on management projecting at least 6.0% adjusted EBITDA margin for FY2026, as lower targets would signal stalled profitability and warrant a thesis downgrade. Given high valuations and persistent insider selling overhangs, any guidance miss could exacerbate sentiment-driven declines, while strong metrics might offer a reprieve but require sustained execution. Investors must also monitor updates on the SmartEquine acquisition and customer metrics like Autoship penetration to gauge long-term resilience. Ultimately, this announcement shifts focus from anticipation to hard data, with implications for portfolio positioning based on the forthcoming financial details.

Thesis delta

The thesis remains unchanged until specific financials and guidance are disclosed, but the announcement moves the catalyst from future event to immediate scrutiny. Any deviation from expected gross margin expansion or FY2026 adjusted EBITDA targets could weaken the potential buy rating, necessitating a reassessment of operating leverage assumptions. Conversely, confirmation of structural margin gains would reinforce the bullish case, though investor confidence must still contend with high multiples and insider selling pressures.